Hyloris Pharmaceuticals【HYL】銘柄情報 | ADVFN

US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
ヨーロッパ
EU
Hyloris Pharmaceuticals SA (HYL) 銘柄情報

Hyloris Pharmaceuticals SA (HYL)

3.30

-0.70

(-17.50%)

終了 11月19日 1:30AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

3.30

買値

3.30

売値

3.50

出来高

51,004

3.28 日の範囲 4.00

2.89 52 週間の範囲 13.30

時価総額

前日終値

4.00

始値

3.98

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

10,404

発行済株式数

28,000,000

配当利回り

-

PER

-6.01

1 株当たり利益 (EPS)

-0.55

歳入

4.21M

純利益

-15.38M

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.hyloris.com

本社

Liege, Liege, Bel

設立

-

Hyloris Pharmaceuticals SA is listed in the Pharmaceutical Preparations sector of the ユーロネクスト with ticker HYL. The last closing price for Hyloris Pharmaceuticals was 4.00 €. Over the last year, Hyloris Pharmaceuticals shares have traded in a share price range of 2.89 € to 13.30 €.

Hyloris Pharmaceuticals currently has 28,000,000 shares in issue. The market capitalisation of Hyloris Pharmaceuticals is 112.00 € million. Hyloris Pharmaceuticals has a price to earnings ratio (PE ratio) of -6.01.

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Le total des produits et autres revenus atteint 4,4...

Communiqué à la requête de la FSMA sur les transactions avec QliniQ

Communiqué à la requête de la FSMA sur les transactions avec QliniQ Communiqué à la requête de la FSMA sur les transactions avec QliniQ Retraitement des états financiers de 2022 et de juin...

Hyloris to Report 2023 Full-Year Results on 14 March 2024

Hyloris to Report 2023 Full-Year Results on 14 March 2024 Liège, Belgium – 08 February 2024, 07:00 AM CET – Non-regulated information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a...

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Maxigesic® IV, a Potent Non-opioid...

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.45	-30.5263157895	4.75	4.79	3.28	14729	4.27377837	DE
4	-2.54	-43.4931506849	5.84	6.2	3.28	9485	5.15948986	DE
12	-3.28	-49.8480243161	6.58	6.58	3.28	10404	5.6171317	DE
26	-8.4	-71.7948717949	11.7	11.7	2.89	15100	5.72548218	DE
52	-9.2	-73.6	12.5	13.3	2.89	12609	8.27279988	DE
156	-11.8	-78.1456953642	15.1	19.1	2.89	7525	10.97404218	DE
260	-7.45	-69.3023255814	10.75	19.1	2.89	8965	11.42432261	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
MHMMyHotelMatch	0.598 € (71.84%)	72.21k
CNVCnova NV	1.125 € (60.71%)	14.78k
EMGDSEuromedis DS	0.015 € (36.36%)	11.96k
MLNMAMiguet Et Associes	0.0995 € (24.38%)	650
EBUSEbusco Holding NV	1.51 € (19.27%)	944.29k
EBUSREbusco	0.0003 € (-99.81%)	6.18M
MLONEBody One	0.24 € (-25.00%)	3.18k
ALSPWSpineway	0.1066 € (-18.00%)	2.22M
HYLHyloris Pharmaceuticals SA	3.30 € (-17.50%)	51k
ALVERVergnet	0.0049 € (-15.52%)	9.6M
ALNEVNeovacs	0.0002 € (0.00%)	43.54M
BCPBanco Comercial Portugues SA	0.4476 € (0.65%)	24.98M
ALHPIHopium SA	0.0098 € (-2.00%)	19.79M
ALCYBCybergun	0.0001 € (0.00%)	12.96M
ALVERVergnet	0.0049 € (-15.52%)	9.6M

rosemountbomber

rosemountbomber 17秒前

Kind of a disappointing price action today but at least not a very high volume.

AverageJoe

AverageJoe 1分前

At least dreamhouse33 clicks "rocket emoji" for moral support while NSAV tanks

Hoskuld

Hoskuld 4分前

Many pre-commercial life sciences companies do drop to 50% of cash in the bank Hosai? Why? Because that cash will all be spent - it is fuel and if investors don't believe it is enough fuel then cash counts for very little. I don't think that will happen here and agree that schizophrenia trial is

martyDg

martyDg 4分前

2024 is the worst year of NWBO!

baldeagle9999

baldeagle9999 5分前

Agreed! Welcome back!

Welcome back Niko! Enjoy the Ride!!! BOOM! IMMINENT!

zab

Going forward 1/2 of America will look at trump and the Republicans and never trust whatever they say or do.

OMOLIVES

OMOLIVES 6分前

I know that BRU Llc was owed a minimal of 1.2 Billion shares in August. These shares were not issued. They were not issued in September either. They were, however, issued after the Authorized was raised in mid October.

Such was signed on 11-1- 2024 by Oren Litwin, who is BR

martyDg

martyDg 6分前

This year is literally "nothing burger" compared to previous years at least there's a significant pump that one can escape out of this stock if they decided to but this year is like no way out for anybody. It's really going to be a Sink or Swim scenario depending on the outcome of MAA. style="font-

CommodityCoverage

CommodityCoverage 6分前

Climbing above $2,600 after hitting a two-month low, investing in gold continues to look promising. Amid geopolitical and economic uncertainties, gold remains reactive to shifts in US monetary policy, global tensions, and investor sentiment. Significantly, recent US support for Ukraine has escalated

RobotDroid

RobotDroid 7分前

It's only going lower for the rest of 2024 into 2025. This crew can't even put a pr together, much less get approval.

leverage102

leverage102 7分前

shurtha2000

shurtha2000 7分前

SVMH added here after hours

Hoghead7

Hoghead7 8分前

It would actually be $850+ at 30 X. However, I have explained my new targets and clearly stated it is not investing advice. $30 should be an easy target, without resistance industry related, since that would only be $600M market cap and we have $300M cash with $1.2B backlog, and that would be equa

WhAtEvA1

WhAtEvA1 8分前

delerious1

delerious1 8分前

Companies, even legit will go to extreme means to keep functioning with the dream of success is sight....doesn't make them a scam

"You have already reached the 1 post per day limit placed on you for this board.
The limitation is until further notice." Shelly

PROPHET-of-PROFITS

PROPHET-of-PROFITS 9分前

You're going on ignore from here on out. I've wasted enough on questions you can answer for yourself.

Have a nice life lolol

stockinspector

stockinspector 9分前

Why not list a couple of them so someone can expose you as uneducated?
The good part is it is never too late to get smarter, or so they say.

weedtrader420

weedtrader420 9分前

it would’ve been a good deal, Elon is so smart✊😎

learningcurve2020

learningcurve2020 10分前

Same weird emojis as over on NWBO. Go figure.

Hopeforthefuture3

Hopeforthefuture3 10分前

Gary, good strategy, just have to do it soon so can still sell the higher priced shares by year end and have passed the 31 days. Previously I have just sold in November and bought back in December 31+ days later. I might just use your strategy this year just in case MHRA decision comes this Decembe

Hyloris Pharmaceuticals

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約